Sanofi’s Jevtana® (cabazitaxel) Not Obvious over Docetaxel Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC (Fed. Cir. 2019) CAFC Panel: Circuit Judges Lourie, Moore, and Taranto Opinion by Circuit Judge Lourie See Patent Doc’s Post: https://www.patentdocs.org/2019/08/sanofi-aventis-us-llc-v-dr-reddys-laboratories-inc-fed-cir-2019.html https://www.jevtana.com/ Share:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to print (Opens in new window)
